XML 38 R28.htm IDEA: XBRL DOCUMENT
v3.8.0.1

STOCK OPTIONS | 3 Months Ended
--- | ---
Sep. 30, 2017
Notes to Financial Statements |
STOCK OPTIONS | On September 24, 2007, the Company’s Board of Directors unanimously adopted the 2007 Employee Stock Option Plan (the “2007 Employee Plan”) and the 2007 Directors Equity Incentive Plan (the “2007 Directors Plan”) each of which was approved by the shareholders on December 3, 2007. Each of those plans was amended by the Board in 2010 to increase the number of shares covered thereby, which amendments were approved by the shareholders on December 14, 2010. The Board also amended the 2007 Directors Plan in November 2013 to further increase the number of shares covered thereby from 400,000 shares to 500,000 shares, which amendment was approved by the shareholders on December 9, 2013. Each of those plans terminated by its respective terms on September 24, 2017. The 2007 Employee Plan provided for awards of up to 600,000 shares of the Company’s Common Stock to employees, consultants and advisors. The 2007 Directors Plan provided for awards of up to 500,000 shares of the Company’s Common Stock to the members of the Board of Directors in the form of non-qualified options and restricted stock. These two plans were administered by the Board, which also established the terms of the awards. Assumptions The fair value for the options granted were estimated using the Black-Scholes option pricing model with the following weighted average assumptions, assuming no expected dividends:
|  | Three Months Ended September 30,
|  | 2017 |  | 2016
Expected volatility |  |  | 60.41% to 104.94 % |  |  |  | 60.41% to 104.94 % |
Risk-free interest rate |  |  | 0.30% to 0.78 % |  |  |  | 0.30% to 0.78 % |
Expected life (years) |  |  | 2.50 |  |  |  | 2.50 |
The expected volatilities are based on the historical volatility of the Company’s stock. Due to higher volatility, the observation is made on a daily basis. The observation period covered is consistent with the expected life of options. The expected life of the options granted to employees has been determined utilizing the “simplified” method as prescribed by ASC Topic 718 Stock Based Compensation, which, among other provisions, allows companies without access to adequate historical data about employee exercise behavior to use a simplified approach for estimating the expected life of a "plain vanilla" option grant. The simplified rule for estimating the expected life of such an option is the average of the time to vesting and the full term of the option. The risk-free rate is consistent with the expected life of the stock options and is based on the United States Treasury yield curve in effect at the time of grant. 2007 Employee Stock Option Plan The Company’s 2007 Employee Plan terminated by its terms on September 24, 2017 and no further options may be granted thereunder. However, the options outstanding thereunder continue to remain outstanding and in effect in accordance with their terms. The Employee Plan permitted the grant of stock options to its employees covering up to an aggregate of 600,000 shares of Common Stock. Under the 2007 Employee Plan, all options were required to be granted with an exercise price of not less than fair value as of the grant date and the options granted were required to exercisable within a maximum of ten years after the date of grant, or such lesser period of time as is set forth in the stock option agreements. The options were permitted to be exercisable (a) immediately as of the effective date of the stock option agreement granting the option, or (b) in accordance with a schedule related to the date of the grant of the option, the date of first employment, or such other date as may be set by the Compensation Committee. Generally, options granted under the 2007 Employee Plan are exercisable within five years after the date of grant, and vest over the period as follows: 25% vesting on the grant date and the remaining balance vesting in equal installments on the next three succeeding anniversaries of the grant date. The share-based compensation will be recognized in terms of the grade method on a straight-line basis for each separately vesting portion of the award. Certain option awards provide for accelerated vesting if there is a change in control (as defined in the 2007 Employee Plan). The Company did not grant any options pursuant to the 2007 Employee Plan during the three months ended September 30, 2017. There were no options exercised during the three months ended September 30, 2017. The Company recognized stock-based compensation expenses of $1 in the three months ended September 30, 2017 under the 2007 Employee Plan. The balance of unamortized stock-based compensation of $4 based on fair value on the grant date related to options granted under the 2007 Employee Plan is to be recognized over a period of three years. The weighted-average remaining contractual term for non-vested options was 3.97 years. The Company did not grant any options pursuant to the 2007 Employee Plan during the three months ended September 30, 2016. There were no options exercised during the three months ended September 30, 2016. The Company recognized stock-based compensation expenses of $1 in the three months ended September 30, 2016 under the 2007 Employee Plan. The balance of unamortized stock-based compensation of $3 based on fair value on the grant date related to options granted under the 2007 Employee Plan is to be recognized over a period of three years. The weighted-average remaining contractual term for non-vested options was 3.96 years. As of September 30, 2017, there were vested employee stock options covering a total of 79,375shares of Common Stock. The weighted-average exercise price was $3.36 and the weighted average contractual term was 2.11 years. As of September 30, 2016, there were vested employee stock options covering a total of 51,250 shares of Common Stock. The weighted-average exercise price was $3.28 and the weighted average contractual term was 2.57 years. A summary of option activities under the 2007 Employee Plan during the three months ended September 30, 2017 is presented as follows:
|  | Options |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Term (Years) |  | Aggregate Intrinsic Value
Outstanding at July 1, 2017 |  |  | 127,500 |  |  | $ | 3.52 |  |  |  | 3.10 |  |  | $ | 187 |
Granted |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Exercised |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Forfeited or expired |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Outstanding at September 30, 2017 |  |  | 127,500 |  |  | $ | 3.52 |  |  |  | 2.85 |  |  | $ | 220 |
Exercisable at September 30, 2017 |  |  | 79.375 |  |  | $ | 3.36 |  |  |  | 2.11 |  |  | $ | 149 |
A summary of option activities under the 2007 Employee Plan during the three months ended September 30, 2016 is presented as follows:
|  | Options |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Term (Years) |  | Aggregate Intrinsic Value
Outstanding at July 1, 2016 |  |  | 90,000 |  |  | $ | 3.26 |  |  |  | 3.42 |  |  | $ | 30 |
Granted |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Exercised |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Forfeited or expired |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Outstanding at September 30, 2016 |  |  | 90,000 |  |  | $ | 3.26 |  |  |  | 3.17 |  |  | $ | 31 |
Exercisable at September 30, 2016 |  |  | 51,250 |  |  | $ | 3.28 |  |  |  | 2.57 |  |  | $ | 17 |
A summary of the status of the Company’s non-vested employee stock options during the three months ended September 30, 2017 is presented below:
|  | Options |  | Weighted Average Grant-Date Fair Value
| Non-vested at July 1, 2017 |  |  |  | 48,125 |  |  | $ | 3.77 |
| Granted |  |  |  | — |  |  |  | — |
| Vested |  |  |  | — |  |  |  | — |
| Forfeited |  |  |  | — |  |  |  | — |
| Non-vested at September 30, 2017 |  |  |  | 48,125 |  |  | $ | 3.77 |
A summary of the status of the Company’s non-vested employee stock options during the three months ended September 30, 2016 is presented below:
|  | Options |  | Weighted Average Grant-Date Fair Value
| Non-vested at July 1, 2016 |  |  |  | 38,750 |  |  | $ | 3.22 |
| Granted |  |  |  | — |  |  |  | — |
| Vested |  |  |  | — |  |  |  | — |
| Forfeited |  |  |  | — |  |  |  | — |
| Non-vested at September 30, 2016 |  |  |  | 38,750 |  |  | $ | 3.22 |
2007 Directors Equity Incentive Plan The 2007 Directors Plan terminated by its terms on September 24, 2017 and no further options may be granted thereunder. However, the options outstanding thereunder continue to remain outstanding and in effect in accordance with their terms. The Director Plan permitted the grant of options covering up to an aggregate of 500,000 shares of Common Stock to its directors in the form of non-qualified options and restricted stock. The exercise price of the non-qualified options is 100% of the fair value of the underlying shares on the grant date. The options have five-year contractual terms and are generally exercisable immediately as of the grant date. During the first quarter of fiscal year 2018, the Company did not grant any options pursuant to the 2007 Directors Plan. There were no stock options exercised during the three-month period ended September 30, 2017. The Company did not recognize any stock-based compensation expenses during the three months ended September 30, 2017. During the first quarter of fiscal year 2017, the Company did not grant any options pursuant to the 2007 Directors Plan. There were no stock options exercised during the three-month period ended September 30, 2016. The Company did not recognize any stock-based compensation expenses during the three months ended September 30, 2016. As of September 30, 2017, there were vested stock options granted under the 2007 Directors Plan covering a total of 415,000 shares of Common Stock. The weighted-average exercise price was $3.36 and the weighted average remaining contractual term was 2.68 years. Both the aggregate intrinsic value of such stock options outstanding and the aggregate intrinsic value of such options exercisable as of September 30, 2017 were $781. As all of the stock options granted under the 2007 Directors Plan vest immediately at the date of grant, there were no unvested stock options granted under the 2007 Directors Plan as of September 30, 2017. As of September 30, 2016, there were vested stock options granted under the 2007 Directors Plan covering a total of 415,000 shares of Common Stock. The weighted-average exercise price was $3.14 and the weighted average remaining contractual term was 3.04 years. Both the aggregate intrinsic value of such stock options outstanding and the aggregate intrinsic value of such options exercisable as of September 30, 2016 were $204. As all of the stock options granted under the 2007 Directors Plan vest immediately at the date of grant, there were no unvested stock options granted under the 2007 Directors Plan as of September 30, 2016. A summary of option activities under the 2007 Directors Plan during the three months ended September 30, 2017 is presented as follows:
|  | Options |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Term (Years) |  | Aggregate Intrinsic Value
Outstanding at July 1, 2017 |  |  | 415,000 |  |  | $ | 3.36 |  |  |  | 2.93 |  |  | $ | 673 |
Granted |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Exercised |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Forfeited or expired |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Outstanding at September 30, 2017 |  |  | 415,000 |  |  | $ | 3.36 |  |  |  | 2.68 |  |  | $ | 781 |
Exercisable at September 30, 2017 |  |  | 415,000 |  |  | $ | 3.36 |  |  |  | 2.68 |  |  | $ | 781 |
A summary of option activities under the 2007 Directors Plan during the three months ended September 30, 2016 is presented as follows:
|  | Options |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Term (Years) |  | Aggregate Intrinsic Value
Outstanding at July 1, 2016 |  |  | 415,000 |  |  | $ | 3.14 |  |  |  | 3.29 |  |  | $ | 198 |
Granted |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Exercised |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Forfeited or expired |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Outstanding at September 30, 2016 |  |  | 415,000 |  |  | $ | 3.14 |  |  |  | 3.04 |  |  | $ | 204 |
Exercisable at September 30, 2016 |  |  | 415,000 |  |  | $ | 3.14 |  |  |  | 3.04 |  |  | $ | 204 |

X
- References No definition available. + Details
Name: | TRT_NotesToFinancialStatementsAbstract
Namespace Prefix: | TRT_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -URI http://asc.fasb.org/subtopic&trid=2208855 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration